Is the cyclosporiasis outbreak slowing? Test-makers are hopeful

by | Aug 1, 2026 | Science

Is the cyclosporiasis outbreak slowing? Test-makers are hopeful

A manufacturer of diagnostic testing equipment indicated in late July that the cyclosporiasis outbreak affecting the United States may be decelerating. The outbreak of infections caused by a parasitic organism had reached more than 18,000 suspected and confirmed cases, representing the nation’s largest recorded occurrence of the illness.

John Osiecki, vice-president of medical affairs at bioMerieux, expressed cautious optimism about the trajectory based on data from the company’s testing panels. The French diagnostics firm tracks testing positivity rates through its Syndromic Trends program, which has detected a decline in positive results. Osiecki attributed potential improvement partly to increased public awareness, noting that heightened consumer consciousness about food safety has influenced purchasing decisions regarding lettuce, a key vector for transmission.

However, significant uncertainties cloud interpretation of the data. bioMerieux’s testing panel screens for multiple gastrointestinal pathogens, not solely cyclosporiasis, and broader testing participation among the population could artificially lower positivity rates even as case numbers remain elevated. Additionally, Medicare coverage for the $417 test is limited to immunosuppressed patients, potentially skewing the dataset. The federal Centers for Disease Control and Prevention, which uses more rigorous confirmation procedures through case interviews, had confirmed 6,707 cases as of late July with approximately 11,500 additional cases awaiting verification.

The outbreak has concentrated in the Midwest, where infections across nine states have been epidemiologically linked to iceberg lettuce sourced from Taylor Farms’ operations in Mexico. The contaminated produce was distributed across 27 states. Public health researchers have cautioned that documented case counts may underestimate the true scope of illness, particularly given that the FDA is investigating additional outbreaks with undetermined causes. Cases continued to emerge in locations outside the formally designated outbreak zone, including a hospital cafeteria cluster in New Hampshire identified as recently as mid-July.

Article Attribution | Read More at Article Source

Article summary produced by Claude AI